Interview with Medacist President & CEO, David BrzozowskiInterview with Medacist President & CEO, David Brzozowski
Drug Diversion Insights with Terri Vidals
Medacist CEO David Brzozowski discusses how AI is transforming drug diversion monitoring in healthcare.
26:19•24 Feb 2022
How AI is Revolutionising Drug Diversion Monitoring: Insights from Medacist CEO David Brzozowski
“We're trying to close the whole loop on that whole medication use process, from the time it gets in the door to the time it gets in the central pharmacy and then up to the floor.”
Imagine a world where artificial intelligence (AI) is your frontline defense against medication diversion in healthcare. In this episode of 'Drug Diversion Insights', host Terri Vidals chats with David Brzozowski, the President and CEO of Medacist, a company that has been pioneering diversion software surveillance since 1998. Brzozowski shares how Medacist has evolved over the years to offer a cutting-edge diversion monitoring solution, leveraging AI to detect unusual patterns and behaviours among healthcare professionals.
The conversation dives into the nitty-gritty of how AI helps in identifying diversion risks by comparing the behaviours of healthcare workers, auditing data, and reducing false positives. Brzozowski also discusses the collaboration with other companies and the future of diversion monitoring technology. This episode is a must-listen for anyone interested in the intersection of healthcare and technology, offering valuable insights into how AI can help keep patients safe.
Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.
Related Episodes
Similar episodes from other shows in the catalogue.